Kubica, K. and Mazurek, A. 2016. VEMURAFENIB AS A SELECTIVE INHIBITOR OF THE SERINE/THREONINE-PROTEIN KINASE B-RAF, USED IN THE TREATMENT OF MELANOMA. Prospects in Pharmaceutical Sciences. 14, 8 (Dec. 2016), 52–56. DOI:https://doi.org/10.56782/pps.117.